Dialysis with expanded solute removal study
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a special dialysis filter (Elisio HX) that removes more waste products from the blood. It aims to see if this approach improves health outcomes for people on regular in-center hemodialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 60 or older, or 45 to 59 with a history of diabetes.
- You have been on any type of dialysis regularly for at least the past 3 months.
- You currently do in-center hemodialysis 3 or more times per week.
- You have a valid provincial or territorial health insurance card.
- Your kidney doctor thinks this study is safe and appropriate for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a newer type of dialysis called hemodiafiltration with standard hemodialysis to see if it improves certain health measures in people with end-stage kidney disease. It may help determine which method works better for long-term treatment.
This study compares two advanced dialysis methods to see which one removes waste products from the blood better. If you are already on a type of dialysis called expanded hemodialysis, you might be able to join.
This trial compares two types of dialysis (hemodiafiltration and standard hemodialysis) to see which works better for older adults with kidney failure. You may be eligible if you are over 84, have been on dialysis for at least 3 months, and are generally healthy enough to participate.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This trial tests whether a newer, higher-performing dialysis filter helps people with kidney failure and sepsis better than the standard filter. It focuses on patients with high levels of inflammation (measured by a marker called interleukin-6).
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
Hear when a new Chronic Kidney Disease Requiring Hemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.